Applied Therapeutics Expects That Its Q1 Cash And Cash Equivalents Of $146.5M Will Fund The Business Into 2026
Applied Therapeutics Expects That Its Q1 Cash And Cash Equivalents Of $146.5M Will Fund The Business Into 2026
Applied Therapeutics預計,其第一季度現金和現金等價物1.465億美元將爲該業務提供資金到2026年
Applied Therapeutics Expects That Its Q1 Cash And Cash Equivalents Of $146.5M Will Fund The Business Into 2026
Applied Therapeutics預計,其第一季度現金和現金等價物1.465億美元將爲該業務提供資金到2026年
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。